Amyotrophic Lateral Sclerosis Mortality in the United States, 1979–2001

The etiology of nonfamilial amyotrophic lateral sclerosis (ALS) remains unknown. Earlier studies have suggested an increase in the incidence of ALS over time. We performed a retrospective analysis of ALS-associated death rates and trends in the United States for 1979–2001 using death records from the national multiple cause-of-death database. The US average annual age-adjusted ALS death rate was 1.84 per 100,000 persons for 1979 through 1998. Most deaths were among adults ≧65 years of age and the median age at death was 67 years. A small overall increase in the death rate was observed primarily between 1979 and 1983, with a subsequent plateau. This slight change in the overall rate reflected apparent increases in the rates among those persons ≧65 years of age, particularly women, and persons in the 20- to 49-year-old age group. The ALS-associated death rate appeared to differ by geographic area, with a higher occurrence among most northern states. Our findings suggest that the epidemiology of ALS-associated deaths in the United States demonstrated small increases in the overall age-adjusted death rate and in the death rates among elderly women and adults 20–49 years of age. Subpopulations at higher risk for ALS were males, whites, persons ≧65 years of age, and residents of northern states. This study provides information for further studies to examine the epidemiology and risk factors associated with ALS.

[1]  S. Sasaki,et al.  Descriptive Epidemiology of Amyotrophic Lateral Sclerosis in Japan, 1995-2001 , 2005, Journal of epidemiology.

[2]  L. Frati,et al.  Amyotrophic lateral sclerosis and sports: a case–control study , 2005, European journal of neurology.

[3]  C. Armon Excess incidence of ALS in young Gulf War veterans , 2004, Neurology.

[4]  R. Groman,et al.  Racial and Ethnic Disparities in Health Care , 2004, Annals of Internal Medicine.

[5]  H. Ehrenreich,et al.  Soccer, neurotrauma and amyotrophic lateral sclerosis: is there a connection? , 2004, Current medical research and opinion.

[6]  H. Hummerich,et al.  Paradigms for the identification of new genes in motor neuron degeneration , 2003, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[7]  M. Strong,et al.  Amyotrophic lateral sclerosis: A review of current concepts , 2003, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[8]  E. Granieri,et al.  Incidence of Amyotrophic Lateral Sclerosis in the Local Health District of Ferrara, Italy, 1964–1998 , 2003, Neuroepidemiology.

[9]  C. Armon An Evidence-Based Medicine Approach to the Evaluation of the Role of Exogenous Risk Factors in Sporadic Amyotrophic Lateral Sclerosis , 2003, Neuroepidemiology.

[10]  A C Gatrell,et al.  Spatial clustering of amyotrophic lateral sclerosis in Finland at place of birth and place of death. , 2003, American journal of epidemiology.

[11]  L. Krivickas,et al.  Amyotrophic lateral sclerosis and other motor neuron diseases. , 2003, Physical medicine and rehabilitation clinics of North America.

[12]  A. Al-Chalabi,et al.  Early symptom progression rate is related to ALS outcome: a prospective population-based study. , 2002, Neurology.

[13]  H M Rosenberg,et al.  Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates. , 2001, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[14]  R. Holman,et al.  Creutzfeldt-Jakob disease in the United States: 1979-1998. , 2000, JAMA.

[15]  M. Riepe,et al.  The role of excitotoxicity in ALS – what is the evidence? , 2000, Journal of Neurology.

[16]  J. Belsh ALS diagnostic criteria of El Escorial Revisited: do they meet the needs of clinicians as well as researchers? , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[17]  E. Alfonsi,et al.  Clustering of ALS patients in central Italy due to the occurrence of the L84F SOD1 gene mutation , 1999, Neurology.

[18]  A. Ludolph,et al.  Problems and pitfalls in the diagnosis of ALS , 1999, Journal of the Neurological Sciences.

[19]  A. Alpérovitch,et al.  Rising amyotrophic lateral sclerosis mortality in France 1968–1990: Increased life expectancy and inter-disease competition as an explanation , 1994, Journal of Neurology.

[20]  J. Slattery,et al.  Risk factors for motor neuron disease: a case-control study based on patients from the Scottish Motor Neuron Disease Register. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[21]  C. Buncher,et al.  Birthplace as a risk factor in motor neurone disease and Parkinson's disease. , 1993, International journal of epidemiology.

[22]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[23]  A. Chiò,et al.  Accuracy of death certificate diagnosis of amyotrophic lateral sclerosis. , 1992, Journal of epidemiology and community health.

[24]  L. Kurland,et al.  Epidemiologic correlates of sporadic amyotrophic lateral sclerosis , 1991, Neurology.

[25]  J. Annegers,et al.  Incidence and prevalence of amyotrophic lateral sclerosis in Harris County, Texas, 1985-1988. , 1991, Archives of neurology.

[26]  O. Axelson,et al.  Amyotrophic lateral sclerosis in Sweden in relation to occupation , 1991, Acta neurologica Scandinavica.

[27]  J M Belsh,et al.  Misdiagnosis in patients with amyotrophic lateral sclerosis. , 1990, Archives of internal medicine.

[28]  T. Munsat,et al.  Excitotoxins and amyotrophic lateral sclerosis. , 1990, The´rapie (Paris).

[29]  T. Flaten RISING MORTALITY FROM MOTONEURON DISEASE , 1989, The Lancet.

[30]  D. Perl,et al.  RISING MORTALITY FROM MOTONEURON DISEASE IN THE USA, 1962-84 , 1989, The Lancet.

[31]  L. Kurland,et al.  Amyotrophic lateral sclerosis and parkinson's disease complex on Guam linked to an environmental neurotoxin , 1988, Trends in Neurosciences.

[32]  P. Nunn,et al.  Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. , 1987, Science.

[33]  Edward L. Frome,et al.  Poisson Regression Analysis , 1981 .

[34]  B. Patten,et al.  Antecedent events in amyotrophic lateral sclerosis , 1976, Neurology.

[35]  M. Jokelainen,et al.  The distribution of amyotrophic lateral sclerosis in Finland , 1975, Journal of the Neurological Sciences.

[36]  F. Eugene Yates,et al.  The national center for health statistics , 1973, Annals of Biomedical Engineering.

[37]  Kurtzke Jf Risk factors in amyotrophic lateral sclerosis. , 1991 .

[38]  J. Taylor,et al.  Amyotrophic lateral sclerosis. A case-control study following detection of a cluster in a small Wisconsin community. , 1990, Archives of neurology.

[39]  C. Molgaard,et al.  Amyotrophic lateral sclerosis and occupational heavy metal exposure: a case-control study. , 1986, Neuroepidemiology.

[40]  A. B. Das-Chaudhuri A twin study of the structure of human hair medulla. , 1976, Human heredity.